The conference remains scheduled as planned (July 15-18, 2005) in San Juan, Puerto Rico. Inclement weather has been reported for this region; however Puerto Rico is due to experience heavy rains this week. Please check back to our site for additional conference updates. Thank you. |
Opening Ceremony
Friday, July 15, 2005 at 6:00pm
The Opening Ceremony kicks off the ISHIB2005 scientific sessions; the conference co-chairs, Drs. Kenneth Jamerson and Kwame Osei will discuss the overall conference theme and objectives. During this session, ISHIB recognizes individuals and organizations for their support, contributions, and special advances in medical research and community service. The ISHIB Board of Trustees and President, Dr. Charles L. Curry will present the distinguished ISHIB2005 President's Lifetime Achievement Award to Dr. Edward Roccella, Coordinator of the National High Blood Pressure Education Program; NHLBI, National Institutes of Health, during the opening ceremonies. This award is presented annually to an individual who has demonstrated a lifelong commitment to reducing health disparities in ethnic minority populations impacting the health of communities across the nation. The Society is proud to honor Dr. Roccella for his accomplishments and leadership role in protecting the health of this nation.
We are additionally honored to have Dr. Myriam Allende-Vigo, Past President, Puerto Rican Society of Endocrinology & Diabetology who will present the Neil Shulman Lecture and distinguished guest Dr. Manuel Martínez-Maldonado, President and Dean of the Ponce School of Medicine.
Join us for a fun filled party in the sand! The President's Reception will present delicious native food along with Latin style music. Be sure to attend. (Casual Attire)
Impressive advances in treating many chronic diseases have been heralded over the last few decades. Life expectancy has increased significantly for both men and women in the US, moreover the numbers of years of health living has increased. However, despite the tremendous gains, significant differences in healthcare outcomes continue to persist in certain ethnic minorities, who continue to remain at a serious disadvantage for receiving optimal medical care.
The disparate incidence of heart, kidney, and neurologic disease among minority populations signals a gap in US healthcare delivery. African Americans develop risk factors for cardiovascular disease at alarming rates compared to the general population. Nearly 4 in every 10 African-American adults have cardiovascular disease. Amongst Hispanic Americans, there is a disparate burden of risk factors for CVD including obesity and diabetes.
In order to address ethnic disparities, ISHIB will convene its 20th annual conference (ISHIB2005) in San Juan, Puerto Rico. The conference will bring together leading healthcare practitioners, researchers, and public health professionals from around the world to share ideas and generate solutions to bridge the gap in minority health.
The ISHIB Board of Trustees appointed Kenneth Jamerson, MD (University of Michigan Health Center) and Kwame Osei, MD (Ohio State University Medical Center) as Scientific Co-Chairs. The Scientific Co-Chairs have assembled a multidisciplinary planning committee dedicated to developing a challenging, clinically practical, educational and networking experience. The Scientific Program will feature 3 plenary sessions, 4 workshops, 6 symposia, and poster and oral abstracts of new research on cardiovascular disease and other issues of importance to ethnic minority health. The wide range of programming will include findings from the most recent clinical trials, to proven approaches for cardiovascular disease treatment and prevention, to sessions emphasizing behavioral techniques to help patients modify behaviors that affect health.
Supported symposia will address a variety of topics in a 1 1/2 to 2 hours breakfast/lunch/dinner/lecture format. Some topics that will be addressed will include hypertension, diabetes, renal disease and pharmacological advances to include the use of Calcium Channel Blockers, ACE Inhibitors, Recent Advances in Aldosterone Blockade, Target Organ Disease, The Role of ARB's in Cardio Renal Risk Reduction, and a review of recent clinical studies.
Workshops will address all topics covered in plenary sessions in an interactive, peer-directed, topic specific format.
Plenary sessions will evaluate the general guidelines controversy and consensus issues surrounding the public implications of hypertension in ethnic minority populations as well as the role of nurses and other health professionals in the treatment and control of hypertension. Plenary sessions will be conducted in a lecture format and will address the burden of CVD risk factors from childhood throughout adult life, indigent care, basic and clinical science of hypertension and other cardiovascular diseases, congestive heart failure, refractory hypertension and kidney failure. The contemporary treatment of cardiovascular disease will be illustrated with discussion of recent and ongoing clinical trials. Special emphasis will be given to the control of risk factors with the use of powerful pharmacological agents as well as hygienic measures.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society of Hypertension, Inc. and ISHIB. The American Society of Hypertension, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Hypertension, Inc. (ASH) designates this educational activity for a maximum of 27 hours in category 1 credit towards AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.
CE CREDITS FOR NURSES, DIETITIANS, AND OTHER HEALTHCARE PROFESSIONALS requiring continuing education credits will be provided by ISHIB. ISHIB has been reviewed and approved as an authorized provider by the International Association for Continuing Education and Training (IACET) and uses the criteria and guidelines designated by that organization as the basis of granting continuing education units (CEUs). Our continued approval by IACET was awarded in May 2001 and is in effect through May 2006. Participants who successfully complete this activity can receive up to 2.7 CEUs.
CE CREDITS FOR PHARMACISTS will be provided by the National Pharmaceutical Association (NPha).
ASH, Inc. strives to insure balance, independence, objectivity, and scientific rigor in all of its educational activities. All participants in such activities are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the session in which they are participating. This pertains to relationships, in place at the time of the activity or in the twelve (12) months preceding the activity, with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Speakers are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
